Abstract
A four- and a half-month-old girl with severe dilated cardiomyopathy due to neonatal enterovirus myocarditis, treated with diuretics and milrinone for the past 4 months, was infected with SARS-CoV-2. The disease course was characterised by high fever and gastrointestinal symptoms. Cardiac function, as measured by echocardiography, remained stable. The treatment focused on maintaining a normal heart rate and a stable fluid balance. In children with severe underlying cardiac disease, even a mild SARS-CoV-2 infection can require close monitoring and compound treatment.
Keywords:
COVID-19; SARS-CoV-2; dilated cardiomyopathy; heart failure; infant.
MeSH terms
-
COVID-19 / complications
-
COVID-19 / physiopathology*
-
Cardiomyopathy, Dilated / drug therapy
-
Cardiomyopathy, Dilated / etiology
-
Cardiomyopathy, Dilated / metabolism
-
Cardiomyopathy, Dilated / physiopathology*
-
Cardiotonic Agents / therapeutic use
-
Diarrhea / physiopathology*
-
Diuretics / therapeutic use
-
Echocardiography
-
Enterovirus Infections / complications
-
Female
-
Fever / physiopathology*
-
Heart Rate
-
Heart Transplantation
-
Humans
-
Infant
-
Milrinone / therapeutic use
-
Myocarditis / complications
-
Natriuretic Peptide, Brain / metabolism
-
Peptide Fragments / metabolism
-
SARS-CoV-2
-
Severity of Illness Index
-
Tachycardia / physiopathology*
-
Tachypnea / physiopathology*
-
Troponin T / metabolism
-
Ventricular Dysfunction, Left / drug therapy
-
Ventricular Dysfunction, Left / etiology
-
Ventricular Dysfunction, Left / metabolism
-
Ventricular Dysfunction, Left / physiopathology*
-
Vomiting / physiopathology*
-
Waiting Lists
-
Water-Electrolyte Balance
Substances
-
Cardiotonic Agents
-
Diuretics
-
Peptide Fragments
-
Troponin T
-
pro-brain natriuretic peptide (1-76)
-
Natriuretic Peptide, Brain
-
Milrinone